Literature DB >> 319362

Enzymology of cancer cells (first of two parts).

G Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 319362     DOI： 10.1056/NEJM197703032960905

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  64 in total

1.  Induction of chromosomal instability by chronic oxidative stress.

Authors:  Charles L Limoli; Erich Giedzinski
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

Review 2.  Use of positron emission tomography in anticancer drug development.

Authors:  Eric O Aboagye; Patricia M Price
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

3.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

Review 4.  Molecular imaging for personalized cancer care.

Authors:  Moritz F Kircher; Hedvig Hricak; Steven M Larson
Journal:  Mol Oncol       Date:  2012-03-10       Impact factor: 6.603

5.  Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.

Authors:  T Miyauchi; R L Wahl
Journal:  Eur J Nucl Med       Date:  1996-05

Review 6.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

7.  Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case.

Authors:  S Yasuda; S Raja; K F Hubner
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Difference in thymidylate synthetase activity in involved nodes compared with primary tumor in breast cancer patients.

Authors:  K Komaki; Y Kamamura; Y Ohmine; M Sasa; K Tanaka; H Inoue; T Uyama; T Morimoto; Y Monden
Journal:  Breast Cancer Res Treat       Date:  1995-08       Impact factor: 4.872

9.  Combination treatment based on metabolic effects of dinaline.

Authors:  H Schaider; U Haberkorn; E Petru; M R Berger
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 10.  Brain tumors.

Authors:  K L Black; J C Mazziotta; D P Becker
Journal:  West J Med       Date:  1991-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.